Taiwan · Delayed Price · Currency is TWD Heron Neutron Medical Statistics
Total Valuation
TPE:7799 has a market cap or net worth of TWD 92.86 billion. The enterprise value is 92.28 billion.
| Market Cap | 92.86B |
| Enterprise Value | 92.28B |
Important Dates
The next estimated earnings date is Thursday, October 23, 2025.
| Earnings Date | Oct 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:7799 has 140.69 million shares outstanding. The number of shares has increased by 19.48% in one year.
| Current Share Class | 140.69M |
| Shares Outstanding | 140.69M |
| Shares Change (YoY) | +19.48% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | 0.69% |
| Owned by Institutions (%) | 4.60% |
| Float | 67.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 46,242.56 |
| PB Ratio | 69.63 |
| P/TBV Ratio | 71.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -293.53 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -213.29 |
Financial Position
The company has a current ratio of 26.41, with a Debt / Equity ratio of 0.01.
| Current Ratio | 26.41 |
| Quick Ratio | 21.12 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -2,119.51 |
Financial Efficiency
Return on equity (ROE) is -24.81% and return on invested capital (ROIC) is -15.88%.
| Return on Equity (ROE) | -24.81% |
| Return on Assets (ROA) | -15.45% |
| Return on Invested Capital (ROIC) | -15.88% |
| Return on Capital Employed (ROCE) | -23.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 60 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 835.80 |
| 200-Day Moving Average | 544.27 |
| Relative Strength Index (RSI) | 33.44 |
| Average Volume (20 Days) | 846,581 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:7799 had revenue of TWD 2.01 million and -314.39 million in losses. Loss per share was -2.27.
| Revenue | 2.01M |
| Gross Profit | -18.98M |
| Operating Income | -324.29M |
| Pretax Income | -314.39M |
| Net Income | -314.39M |
| EBITDA | -301.58M |
| EBIT | -324.29M |
| Loss Per Share | -2.27 |
Balance Sheet
The company has 580.77 million in cash and 7.54 million in debt, giving a net cash position of 573.23 million or 4.07 per share.
| Cash & Cash Equivalents | 580.77M |
| Total Debt | 7.54M |
| Net Cash | 573.23M |
| Net Cash Per Share | 4.07 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 9.48 |
| Working Capital | 744.15M |
Cash Flow
In the last 12 months, operating cash flow was -387.11 million and capital expenditures -45.56 million, giving a free cash flow of -432.67 million.
| Operating Cash Flow | -387.11M |
| Capital Expenditures | -45.56M |
| Free Cash Flow | -432.67M |
| FCF Per Share | -3.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | -16,149.65% |
| Pretax Margin | -15,656.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPE:7799 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.48% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.34% |
| FCF Yield | -0.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |